The Development of the Walsh Asthma Self-management Programme and Feasibility of Implementation in Adults With Asthma in Primary Care
Asthma is a common medical condition in Ireland. Adult patients tend to have periods when their asthma is stable and periods when it worsens. In order to reduce these periods of worsening asthma, effective ongoing management is required day to day by adults with asthma. Teaching adults how to manage their asthma effectively, plays a huge role in improving their asthma and having a better overall quality of life. This education on managing asthma has many different parts to it. Most adults will discover they have asthma through their general practitioner (GP) and it will be continued to be checked and managed through their GP or general practice nurse (GPN) in their primary care clinic for the duration of their lives.
This research study is taking place to find out if a new education programme, will help adults manage their asthma better and improve the symptoms of asthma, reducing its overall impact on day-to-day life. This study is also looking at how easy it is to introduce and for nurses to deliver this study within a GP/ primary care centre. This study is to find out if this education programme works in a real life setting and if it can lead to better control of asthma for adults.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Joanne Walsh, MSc
- Telefonnummer: 01-4022300
- E-post: joannewalsh21@rcsi.com
Studieorter
-
-
D
-
Dublin, D, Irland, D15 AXV5
- Rekrytering
- Royal College of Surgeons Ireland
-
Kontakt:
- Joanne Walsh, MSc
- Telefonnummer: 01-4022300
- E-post: joannewalsh21@rcsi.com
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- Adults over 18 years old
- Adults who meet one of the following criteria:
a physician's diagnosis of asthma; coded as asthma (R96) as per the international classification of primary care (ICPC) or international classification of diseases (ICD) code J45 with associated use of asthma medications for 6 months prior to study enrolment.
Exclusion Criteria:
- Adults under 18 years old
- Adults with no diagnosis of asthma
- Adults receiving asthma education in a specialist hospital or community setting
- Adults unable to give informed consent
- Smoking ≥ 10 Pack Year History
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Övrig
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: WASP intervetion
|
all participants will received the WASP intervention which includes (asthma education, self-management training and behaviour change strategies)
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Feasibility of implementation
Tidsram: 6 months
|
In terms of: recruitment, retention, response rates and service users' views of the intervention
|
6 months
|
|
Education
Tidsram: 6 months
|
Establish the nurses' frequency of education implementation
|
6 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Asthma Control Test Questionnaire
Tidsram: 6 months
|
To determine level of asthma control
|
6 months
|
|
Modified asthma self-efficacy questionnaire
Tidsram: 6 months
|
To determine level of asthma self-efficacy
|
6 months
|
|
Mini Asthma Quality of Life Questionnaire (mAQLQ)
Tidsram: 6 months
|
To determine level of asthma associated quality of life
|
6 months
|
|
Spirometry - Forced expiratory volume in 1 second (FEV1)
Tidsram: 6 months
|
To monitor lung function - using FEV1
|
6 months
|
|
Spirometry - Forced Vital Capacity (FVC)
Tidsram: 6 months
|
To monitor lung function using FVC measurement
|
6 months
|
|
Spirometry - Peak expiratory flow (PEF)
Tidsram: 6 months
|
To monitor lung function using PEF measurements
|
6 months
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- REC202602014
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .